Detection of melanoma micrometastases in sentinel nodes - The cons

Surgical Oncology

Volumn 17, Issue 3, 2008, Pages 175-181

  de Wilt, Johannes H W ^a   van Akkooi, Alexander C J ^a   Verhoef, Cornelis ^a   Eggermont, Alexander M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Melanoma; Micrometastases; Pathology; Prognosis; Sentinel node

Indexed keywords

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MELANOMA; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SURVIVAL TIME; TUMOR VOLUME; ULTRASOUND;

HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 50049084913     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.06.004     Document Type: Review

References (69)

1. Balch C.M., Buzaid A.C., Soong S.J., Atkins M.B., Cascinelli N., Coit D.G., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19 16 (2001) 3635-3648
2. Balch C.M., Soong S.J., Gershenwald J.E., Thompson J.F., Reintgen D.S., Cascinelli N., et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 16 (2001) 3622-3634
3. Veronesi U., Adamus J., Bandiera D.C., Brennhovd I.O., Caceres E., Cascinelli N., et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 297 12 (1977) 627-630
4. Sim F.H., Taylor W.F., Ivins J.C., Pritchard D.J., and Soule E.H. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 41 3 (1978) 948-956
5. Balch C.M., Soong S., Ross M.I., Urist M.M., Karakousis C.P., Temple W.J., et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7 2 (2000) 87-97
6. Cascinelli N., Morabito A., Santinami M., MacKie R.M., and Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO melanoma programme. Lancet 351 9105 (1998) 793-796
7. Morton D.L., Hoon D.S., Cochran A.J., Turner R.R., Essner R., Takeuchi H., et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 238 4 (2003) 538-549 [discussion 549-50]
8. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 4 (1992) 392-399
9. Reintgen D., Cruse C.W., Wells K., Berman C., Fenske N., Glass F., et al. The orderly progression of melanoma nodal metastases. Ann Surg 220 6 (1994) 759-767
10. Vuylsteke R.J., van Leeuwen P.A., Statius Muller M.G., Gietema H.A., Kragt D.R., and Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 21 6 (2003) 1057-1065
11. McMasters K.M., Reintgen D.S., Ross M.I., Wong S.L., Gershenwald J.E., Krag D.N., et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?. Ann Surg Oncol 8 3 (2001) 192-197
12. Estourgie S.H., Nieweg O.E., Valdes Olmos R.A., Hoefnagel C.A., and Kroon B.B. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 10 6 (2003) 681-688
13. Statius Muller M.G., van Leeuwen P.A., de Lange-De Klerk E.S., van Diest P.J., Pijpers R., Ferwerda C.C., et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 91 12 (2001) 2401-2408
14. Gershenwald J.E., Thompson W., Mansfield P.F., Lee J.E., Colome M.I., Tseng C.H., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 3 (1999) 976-983
15. Thompson J.F., Niewind P., Uren R.F., Bosch C.M., Howman-Giles R., and Vrouenraets B.C. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res 7 6 (1997) 500-506
16. Thompson J.F., Uren R.F., Shaw H.M., McCarthy W.H., Quinn M.J., O'Brien C.J., et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 189 2 (1999) 195-204
17. de Wilt J.H., Thompson J.F., Uren R.F., Ka V.S., Scolyer R.A., McCarthy W.H., et al. Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck. Ann Surg 239 4 (2004) 544-552
18. Uren R.F., Howman-Giles R., Chung D.K., Morton R.L., and Thompson J.F. The reproducibility in routine clinical practice of sentinel lymph node identification by pre-operative lymphoscintigraphy in patients with cutaneous melanoma. Ann Surg Oncol 14 2 (2007) 899-905
19. Doubrovsky A., De Wilt J.H., Scolyer R.A., McCarthy W.H., and Thompson J.F. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 11 9 (2004) 829-836
20. Cook M.G., Green M.A., Anderson B., Eggermont A.M., Ruiter D.J., Spatz A., et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 200 3 (2003) 314-319
21. Ruiter D.J., Spatz A., van den Oord J.J., and Cook M.G. Pathologic staging of melanoma. Semin Oncol 29 4 (2002) 370-381
22. Kretschmer L., Beckmann I., Thoms K.M., Haenssle H., Bertsch H.P., and Neumann C. Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas. Eur J Cancer 41 4 (2005) 531-538
23. Carlson G.W., Murray D.R., Lyles R.H., Staley C.A., Hestley A., and Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 10 5 (2003) 575-581
24. Spanknebel K., Coit D.G., Bieligk S.C., Gonen M., Rosai J., and Klimstra D.S. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol 29 3 (2005) 305-317
25. van Akkooi A.C., de Wilt J.H., Verhoef C., Graveland W.J., van Geel A.N., Kliffen M., et al. High positive sentinel node identification rate by EORTC melanoma group protocol prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 42 3 (2006) 372-380
26. Morton D.L., Cochran A.J., Thompson J.F., Elashoff R., Essner R., Glass E.C., et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 3 (2005) 302-311 [discussion 311-3]
27. Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Elashoff R., Essner R., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 13 (2006) 1307-1317
28. McMasters K.M., Wong S.L., Edwards M.J., Chao C., Ross M.I., Noyes R.D., et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 9 2 (2002) 137-141
29. van Akkooi A.C., Bouwhuis M.G., van Geel A.N., Hoedemaker R., Verhoef C., Grunhagen D.J., et al. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol 33 1 (2007) 102-108
30. Fournier K., Schiller A., Perry R.R., and Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann Surg 239 6 (2004) 859-863 [discussion 863-5]
31. Rutgers E.J. Sentinel node micrometastasis in breast cancer. Br J Surg 91 10 (2004) 1241-1242
32. Starz H., Balda B.R., Kramer K.U., Buchels H., and Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 91 11 (2001) 2110-2121
33. Starz H., Siedlecki K., and Balda B.R. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 11 Suppl. 3 (2004) 162S-168S
34. Lee J.H., Essner R., Torisu-Itakura H., Wanek L., Wang H., and Morton D.L. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 22 18 (2004) 3677-3684
35. Vuylsteke R.J., Borgstein P.J., van Leeuwen P.A., Gietema H.A., Molenkamp B.G., Muller M.G., et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 12 6 (2005) 440-448
36. Reeves M.E., Delgado R., Busam K.J., Brady M.S., and Coit D.G. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 10 1 (2003) 27-31
37. Sabel M.S., Griffith K., Sondak V.K., Lowe L., Schwartz J.L., Cimmino V.M., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 1 (2005) 37-47
38. Scolyer R.A., Li L.X., McCarthy S.W., Shaw H.M., Stretch J.R., Sharma R., et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 122 4 (2004) 532-539
39. Dewar D.J., Newell B., Green M.A., Topping A.P., Powell B.W., and Cook M.G. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22 16 (2004) 3345-3349
40. van Akkooi A.C., de Wilt J.H., Verhoef C., Schmitz P.I., van Geel A.N., Eggermont A.M., et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?. Ann Oncol 17 10 (2006) 1578-1585
41. Gietema H.A., Vuylsteke R.J., van Diest P.J., Meijer S., and van Leeuwen P.A. Predicting nonsentinel lymph node involvement in stage I/II melanoma. Ann Surg Oncol 10 8 (2003) 993 [author reply 993-4]
42. Salti G.I., and Das Gupta T.K. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg 186 2 (2003) 98-101
43. Debarbieux S., Duru G., Dalle S., Beatrix O., Balme B., and Thomas L. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 157 1 (2007) 58-67
44. Ranieri J.M., Wagner J.D., Azuaje R., Davidson D., Wenck S., Fyffe J., et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 9 10 (2002) 975-981
45. Govindarajan A., Ghazarian D.M., McCready D.R., and Leong W.L. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 14 2 (2007) 906-912
46. Satzger I., Volker B., Al Ghazal M., Meier A., Kapp A., and Gutzmer R. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 50 6 (2007) 764-772
47. Roka F., Mastan P., Binder M., Okamoto I., Mittlboeck M., Horvat R., et al. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Eur J Surg Oncol 34 1 (2008) 82-88
48. Rossi C.R., De Salvo G.L., Bonandini E., Mocellin S., Foletto M., Pasquali S., et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol (2007)
49. Pearlman N.W., McCarter M.D., Frank M., Hurtubis C., Merkow R.P., Franklin W.A., et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg 192 6 (2006) 878-881
50. van Akkooi A.C., Nowecki Z.I., Voit C., Schaefer G., Michej W., Kliffen M., et al. Prognosis depends on micro-anatomic patterns of melanoma micrometastases within the sentinel node (SN). A multicenter study in 388 SN positive patients. Eur J Cancer - Supplements 5 4 (2007) 397 [abstract 7006]
51. Scoggins C.R., Ross M.I., Reintgen D.S., Noyes R.D., Goydos J.S., Beitsch P.D., et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 24 18 (2006) 2849-2857
52. Satzger I., Volker B., Meier A., Schenck F., Kapp A., and Gutzmer R. Prognostic significance of isolated HMB45 or Melan A positive cells in melanoma sentinel lymph nodes. Am J Surg Pathol 31 8 (2007) 1175-1180
53. Hermanek P., Hutter R.V., Sobin L.H., and Wittekind C. International union against cancer. Classification of isolated tumor cells and micrometastasis. Cancer 86 12 (1999) 2668-2673
54. Scheri R.P., Essner R., Turner R.R., Ye X., and Morton D.L. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 14 10 (2007) 2861-2866
55. Kretschmer L., Hilgers R., Mohrle M., Balda B.R., Breuninger H., Konz B., et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer 40 2 (2004) 212-218
56. Essner R., Conforti A., Kelley M.C., Wanek L., Stern S., Glass E., et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6 5 (1999) 442-449
57. Thomas J.M. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 5 1 (2008) 18-23
58. van Akkooi A.C., Bouwhuis M.G., de Wilt J.H., Kliffen M., Schmitz P.I., and Eggermont A.M. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg 94 10 (2007) 1293-1299
59. Rutkowski P., Nowecki Z.I., Nasierowska-Guttmejer A., and Ruka W. Lymph node status and survival in cutaneous malignant melanoma-sentinel lymph node biopsy impact. Eur J Surg Oncol 29 7 (2003) 611-618
60. Eggermont A.M., and Gore M. European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma. Semin Oncol 29 4 (2002) 382-388
61. Uren R.F., Howman-Giles R., Thompson J.F., Shaw H.M., Roberts J.M., Bernard E., et al. High-resolution ultrasound to diagnose melanoma metastases in patients with clinically palpable lymph nodes. Australas Radiol 43 2 (1999) 148-152
62. Uren R.F., Sanki A., and Thompson J.F. The utility of ultrasound in patients with melanoma. Expert Rev Anticancer Ther 7 11 (2007) 1633-1642
63. Voit C., Kron M., Schafer G., Schoengen A., Audring H., Lukowsky A., et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann Surg Oncol 13 12 (2006) 1682-1689
64. Voit C., Mayer T., Proebstle T.M., Weber L., Kron M., Krupienski M., et al. Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases. Cancer 90 3 (2000) 186-193
65. Eggermont A.M. Reducing the need for sentinel node procedures by ultrasound examination of regional lymph nodes. Ann Surg Oncol 12 1 (2005) 3-5
66. Starritt E.C., Uren R.F., Scolyer R.A., Quinn M.J., and Thompson J.F. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 12 1 (2005) 18-23
67. Bafounta M.L., Beauchet A., Chagnon S., and Saiag P. Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis. Lancet Oncol 5 11 (2004) 673-680
68. Voit C., van Akkooi A.C.J., Schaefer-Hesterberg G., Schoengen A., Sterry W., and Eggermont A.M.M. Reduction of need for operative sentinel node procedure in melanoma patients: fifty percent identification rate of sentinel node positivity by ultrasound (US)-guided fine needle aspiration cytology (FNAC) in 400 consecutive patients. Eur J Cancer Suppl 5 6 (2007) 11 [abstract 3BA]
69. Kuenen-Boumeester V., Menke-Pluymers M., de Kanter A.Y., Obdeijn I.M., Urich D., and Van Der Kwast T.H. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer 39 2 (2003) 170-174